Literature DB >> 2493108

Enhanced high energy phosphate recovery with ribose infusion after global myocardial ischemia in a canine model.

J A St Cyr1, R W Bianco, J R Schneider, J R Mahoney, K Tveter, S Einzig, J E Foker.   

Abstract

High energy phosphate levels are depressed following global ischemia and require several days to completely recover. Short-term methods to enhance ATP recovery have included infusion of ATP precursors, inhibition of enzymes that catabolize AMP, and membrane transport stabilization. Several precursors have been used to augment adenine nucleotide synthesis including adenosine, inosine, adenine, and ribose. Because of the short-term nature of previous experiments, recovery had been incomplete and the effects in the intact animal unknown. The purpose of this study was to determine the effects of ribose infusion in a long-term model of global ischemia and attempt to identify the precursor which limits myocardial ATP regeneration in the intact animal. Global myocardial ischemia (20 min, 37 degrees C) was produced in dogs on cardiopulmonary bypass. With reperfusion either ribose (80 mM) in normal saline or normal saline alone was infused at 1 ml/min into the right atrium and the animals were followed for 24 hr. Ventricular biopsies were obtained through an indwelling ventricular cannula prior to ischemia, at the end of ischemia, and 4 and 24 hr postischemia and analyzed for adenine nucleotides and creatine phosphate levels. Radiolabeled microspheres were used to measure myocardial and renal blood flows and no significant difference was found between ribose-treated control groups. In both groups, myocardial ATP levels fell by at least 50% at the end of ischemia. No significant ATP recovery occurred after 24 hr in the control dogs, but in the ribose-treated animals, ATP levels rebounded to 85% of control by 24 hr.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493108     DOI: 10.1016/0022-4804(89)90220-5

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  8 in total

1.  D-ribose aids heart failure patients with preserved ejection fraction and diastolic dysfunction: a pilot study.

Authors:  Melike Bayram; J A St Cyr; William T Abraham
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-02-19

2.  D-ribose aids congestive heart failure patients.

Authors:  Heyder Omran; Dean McCarter; John St Cyr; Berndt Lüderitz
Journal:  Exp Clin Cardiol       Date:  2004

3.  Ribose Supplementation Alone or with Elevated Creatine Does Not Preserve High Energy Nucleotides or Cardiac Function in the Failing Mouse Heart.

Authors:  Kiterie M E Faller; Debra J Medway; Dunja Aksentijevic; Liam Sebag-Montefiore; Jürgen E Schneider; Craig A Lygate; Stefan Neubauer
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

4.  Understanding D-Ribose and Mitochondrial Function.

Authors:  Diane E Mahoney; John B Hiebert; Amanda Thimmesch; John T Pierce; James L Vacek; Richard L Clancy; Andrew J Sauer; Janet D Pierce
Journal:  Adv Biosci Clin Med       Date:  2018

Review 5.  Mitochondrial bioenergetics and D-ribose in HFpEF: a brief narrative review.

Authors:  Kathryn J Krueger; Faith K Rahman; Qiuhua Shen; James Vacek; John B Hiebert; Janet D Pierce
Journal:  Ann Transl Med       Date:  2021-10

6.  Evaluation of the anti-ischemic effects of D-ribose during dobutamine stress echocardiography: a pilot study.

Authors:  Stephen G Sawada; Stephen Lewis; Roxanne Kovacs; Samer Khouri; Irmina Gradus-Pizlo; John A St Cyr; Harvey Feigenbaum
Journal:  Cardiovasc Ultrasound       Date:  2009-02-07       Impact factor: 2.062

Review 7.  Potential Clinical Benefits of D-ribose in Ischemic Cardiovascular Disease.

Authors:  Linda M Shecterle; Kathleen R Terry; John A St Cyr
Journal:  Cureus       Date:  2018-03-09

8.  A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effectiveness of a Food Supplement Containing Creatine and D-Ribose Combined with a Physical Exercise Program in Increasing Stress Tolerance in Patients with Ischemic Heart Disease.

Authors:  Giuseppe Derosa; Silvia Pasqualotto; Gabriele Catena; Angela D'Angelo; Antonio Maggi; Pamela Maffioli
Journal:  Nutrients       Date:  2019-12-17       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.